Table 2. Primary reason for discontinuation of efavirenza.
| Cause | Number of cases (n = 99) |
Percentage |
|---|---|---|
| Central nervous system symptoms | 29 | 29.3 |
| Rash | 23 | 23.2. |
| Viral drug resistance mutations | 16 | 16.2 |
| Non-adherence | 9 | 9.1 |
| Gastrointestinal side effects | 6 | 6.1 |
| Drug-drug interaction | 2 | 2.0 |
| Hypercholesterolemia | 2 | 2.0 |
| Other | 2 | 2.0 |
| Unspecified | 10 | 10.1 |
Based on review of provider notes in the electronic medical record.